Sai Parenterals Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Sai Parenterals announced that the company's subsidiary Noumed Pharmaceuticals had entered OTC medicines supply agreement with Australia's leading pharmacy network with contract valued at Australian Dollars (AUD) 202 millions (equivalent to Rs 1300 crore; 1 AUD = INR 64.5). The agreement is valid for a period of 7.5 years with a further option of 3 years extension upon mutual consent.

Sai Parenterals has received a purchase order valued at USD 11 million at an exchange rate of Rs 95 (Rs 104.50 crore) from PILL CORP, Bulacan, Philippines. The contract is for supply of anti TB products for the Philippines market on exclusivity basis for a period of 10 years.

Sai Parenteral's will hold a meeting of the Board of Directors of the Company on 23 May 2026.

Sai Parenterals will hold a meeting of the Board of Directors of the Company on 20 April 2026.